Clinical, histologic, and
endoscopic endpoints1,2

DUPIXENT was studied across multiple endpoints.

View the results

Demonstrated
safety profile1

The safety of DUPIXENT was evaluated through 24 weeks in the multi-part, phase 3 clinical trial.

explore the data

Support can make all the difference. DUPIXENT MyWay® is a patient support program that can help enable access to DUPIXENT and offers financial assistance for eligible patients, one-on-one nursing support, and more.

LEARN HOW WE CAN HELP

DUPIXENT MyWay
ENROLLMENT FORMS
FOR GASTROENTEROLOGISTS
English Enrollment Form
Spanish Enrollment Form
FOR ALLERGISTS
Allergist (EoE) English​ ​Enrollment Form
Allergist (EoE) Spanish Enrollment Form
Contact a Field
Representative
Connect with a DUPIXENT Field Representative to get answers to your product-related questions.
CONTACT A REP